Pruritus: An overview of current concepts

Veterinary Dermatology

Volumn 22, Issue 2, 2011, Pages 121-131

  Metz, Martin ^a   Grundmann, Sonja ^b   Ständer, Sonja ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPRURITIC AGENT; HISTAMINE;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; CHRONIC DISEASE; HUMAN; INFLAMMATION; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PRURITUS; REVIEW; URTICARIA;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIPRURITICS; CHRONIC DISEASE; HISTAMINE; HUMANS; INFLAMMATION; PRURITUS; URTICARIA;

ANIMALIA;

EID: 79952363470     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00945.x     Document Type: Review

References (84)

1. Ikoma A, Steinhoff M, Ständer S et al. The neurobiology of itch. Nature Reviews Neuroscience 2006; 7: 535-47.
2. Ständer S, Weisshaar E, Mettang T et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Dermato-Venereologica 2007; 87: 291-4.
3. Weisshaar E, Apfelbacher C, Jager G et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. British Journal of Dermatology 2006; 155: 957-64.
4. Valet M, Pfab F, Sprenger T et al. Cerebral processing of histamine-induced itch using short-term alternating temperature modulation - an fMRI study. Journal of Investigative Dermatology 2008; 128: 426-33.
5. Yosipovitch G, Ishiuji Y, Patel TS et al. The brain processing of scratching. Journal of Investigative Dermatology 2008; 128: 1806-11.
6. Nakano T, Andoh T, Lee JB et al. Different dorsal horn neurons responding to histamine and allergic itch stimuli. Neuroreport 2008; 19: 723-6.
7. Liu Q, Tang Z, Surdenikova L et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 2009; 139: 1353-65.
8. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007; 448: 700-3.
9. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nature Neuroscience 2001; 4: 72-7.
10. Ko MC, Naughton NN. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology 2000; 92: 795-805.
11. Horta ML, Morejon LC, da Cruz AW et al. Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. British Journal of Anaesthesia 2006; 96: 796-800.
12. Ko MC, Song MS, Edwards T et al. The role of central μ opioid receptors in opioid-induced itch in primates. Journal of Pharmacology and Experimental Therapeutics 2004; 310: 169-76.
13. Schmelz M. Itch - mediators and mechanisms. Journal of Dermatological Science 2002; 28: 91-6.
14. Bonnet MP, Marret E, Josserand J et al. Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review. British Journal of Anaesthesia 2008; 101: 311-9.
15. Ständer S, Weisshaar E, Steinhoff M et al. Pruritus - pathophysiology, clinical features and therapy - an overview. Journal der Deutschen Dermatologischen Gesellschaft 2003; 1: 105-18.
16. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008; 213: 251-60.
17. 4 receptors in allergic inflammation: the search for new antihistamines. Nature Reviews Drug Discovery 2008; 7: 41-53.
18. Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Dermato-Venereologica 2007; 87: 196-205.
19. Metz M, Maurer M. Mast cells - key effector cells in immune responses. Trends in Immunology 2007; 28: 234-41.
20. Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. Journal of Neuroscience 2003; 23: 6176-80.
21. 4 in substance P-induced itch-associated response in mice. Journal of Investigative Dermatology 2001; 117: 1621-6.
22. Paus R, Schmelz M, Biro T et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. Journal of Clinical Investigation 2006; 116: 1174-86.
23. Takaoka A, Arai I, Sugimoto M et al. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice. Experimental Dermatology 2007; 16: 331-9.
24. Woodward DF, Nieves AL, Friedlaender MH. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. Journal of Pharmacology and Experimental Therapeutics 1996; 279: 137-42.
25. 2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. Journal of the American Academy of Dermatology 2002; 47: 28-32.
26. Boyce JA. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunological Reviews 2007; 217: 168-85.
27. Siebenhaar F, Magerl M, Peters EM et al. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. Journal of Allergy and Clinical Immunology 2008; 121: 955-61.
28. Steinhoff M, Biro T. A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch. Journal of Investigative Dermatology 2009; 129: 531-5.
29. Bigliardi PL, Stammer H, Jost G et al. Treatment of pruritus with topically applied opiate receptor antagonist. Journal of the American Academy of Dermatology 2007; 56: 979-88.
30. Bigliardi-Qi M, Gaveriaux-Ruff C, Pfaltz K et al. Deletion of μ- and κ-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior. Journal of Investigative Dermatology 2007; 127: 1479-88.
31. Bernstein JE, Swift RM, Soltani K et al. Antipruritic effect of an opiate antagonist, naloxone hydrochloride. Journal of Investigative Dermatology 1982; 78: 82-3.
32. Fjellner B, Hagermark O. The influence of the opiate antagonist naloxone on experimental pruritus. Acta Dermato-Venereologica 1984; 64: 73-5.
33. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-4.
34. Pogatzki-Zahn E, Marziniak M, Schneider G et al. Chronic pruritus: targets, mechanisms and future therapies. Drug News & Perspectives 2008; 21: 541-51.
35. Darsow U, Scharein E, Bromm B et al. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction. British Journal of Dermatology 1997; 137: 415-7.
36. Takaoka A, Arai I, Sugimoto M et al. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Experimental Dermatology 2006; 15: 161-7.
37. Schulz F, Marenholz I, Folster-Holst R et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. Journal of Allergy and Clinical Immunology 2007; 120: 1097-102.
38. Toyoda M, Nakamura M, Makino T et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. British Journal of Dermatology 2002; 147: 71-9.
39. Metz M, Botchkarev VA, Botchkareva NV et al. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin. Experimental Dermatology 2004; 13: 273-81.
40. Raap U, Ikoma A, Kapp A. Neurophysiology of pruritus. Hautarzt 2006; 57: 379-80 82-4.
41. Ikoma A, Handwerker H, Miyachi Y et al. Electrically evoked itch in humans. Pain 2005; 113: 148-54.
42. Terranova M, Guarneri C, Guarneri F et al. Some historical and epistemological remarks on itch and pruritus. Dermatologic Therapy 2005; 18: 283-7.
43. Schmelz M. Complex interactions between pain and itch. Pain 2006; 124: 9-10.
44. Twycross R, Greaves MW, Handwerker H et al. Itch: scratching more than the surface. QJM: An International Journal of Medicine 2003; 96: 7-26.
45. Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatologic Therapy 2005; 18: 288-91.
46. Sommer F, Hensen P, Böckenholt B et al. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Dermato-Venereologica 2007; 87: 510-6.
47. Zuberbier T, Asero R, Bindslev-Jensen C et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-26.
48. Zuberbier T, Asero R, Bindslev-Jensen C et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
49. Darsow U, Wollenberg A, Simon D et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. Journal of the European Academy of Dermatology & Venereology 2009; 24: 317-28.
50. Foster AP, Roosje PJ. Update on feline immunoglobulin E (IgE) and diagnostic recommendations for atopy. In: August JR, ed. Consultations in Feline Internal Medicine, vol. 5. St Louis: Elsevier Saunders, 2005: 229-38.
51. Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Veterinary Dermatology 2010; 21: 4-22.
52. Boden E. Black's Veterinary Dictionary. Lanham, MD: Barnes & Noble Books, 2001.
53. Noxon JO. Anaphylaxis, urticaria, and angioedema. Seminars in Veterinary Medicine & Surgery (Small Animal) 1991; 6: 265-72.
54. Stannard AA. Immunologic diseases. Veterinary Dermatology 2000; 11: 163-78.
55. Cavalcante MC, de Andrade LR, Du Bocage Santos-Pinto C et al. Colocalization of heparin and histamine in the intracellular granules of test cells from the invertebrate Styela plicata (Chordata-Tunicata). Journal of Structural Biology 2002; 137: 313-21.
56. Millar DA, Ratcliffe NA. The evolution of blood cells: facts and enigmas. Endeavour 1989; 13: 72-7.
57. Mulero I, Sepulcre MP, Meseguer J et al. Histamine is stored in mast cells of most evolutionarily advanced fish and regulates the fish inflammatory response. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 19434-9.
58. Rosenberg M, Patterson R, Kelly JF et al. Acute urticaria and bronchospasm following radiographic contrast media in a dog. Journal of Allergy and Clinical Immunology 1977; 59: 339-40.
59. Winters JB. Severe urticarial reaction in a dog following ingestion of tall field buttercup. Veterinary Medicine: Small Animal Clinician 1976; 71: 307.
60. Fadok VA. Overview of equine papular and nodular dermatoses. Veterinary Clinics of North America: Equine Practice 1995; 11: 61-74.
61. Scott DW. Immunologic skin disorders in the dog and cat. Veterinary Clinics of North America: Small Animal Practice 1978; 8: 641-64.
62. Cornick JL, Brumbaugh GW. Dermatographism in a horse. Cornell Veterinarian 1989; 79: 109-16.
63. Stöber M, Trautwein G. Dermatographism (Uriticaria factitia) in a cow. Deutsche Tierarztliche Wochenschrifte 1971; 78: 55-6.
64. Logas D, Kunkle G, Calderwood-Mays M et al. Cholinergic pruritus in a horse. Journal of the American Veterinary Medical Association 1992; 201: 90-1.
65. Murphy GM, Greaves MW, Zollman PE et al. Cholinergic urticaria, passive transfer experiments from human to monkey. Dermatologica 1988; 177: 338-40.
66. Lorch G, Hillier A, Kwochka KW et al. Results of intradermal tests in horses without atopy and horses with atopic dermatitis or recurrent urticaria. American Journal of Veterinary Research 2001; 62: 1051-9.
67. Rüfenacht S, Marti E, von Tscharner C et al. Immunoglobulin E-bearing cells and mast cells in skin biopsies of horses with urticaria. Veterinary Dermatology 2005; 16: 94-101.
68. Miyazawa K, Ito M, Ohsaki K. An equine case of urticaria associated with dry garlic feeding. Journal of Veterinary Medical Science 1991; 53: 747-8.
69. Rees CA. Response to immunotherapy in six related horses with urticaria secondary to atopy. Journal of the American Veterinary Medical Association 2001; 218: 753-5.
70. Radostits OM, Arundel JH. Veterinary Medicine: a Textbook of the Diseases of Cattle, Sheep, Pigs, Goats and Horses. London, New York: Saunders, 2000. p. 109.
71. Rodriguez-Palacios A, Quesada R, Baird J et al. Presumptive fluphenazine-induced hepatitis and urticaria in a horse. Journal of Veterinary Internal Medicine 2007; 21: 336-9.
72. Ständer S, Streit M, Darsow U et al. Diagnostic and therapeutic procedures in chronic pruritus. Journal der Deutschen Dermatologischen Gesellschaft 2006; 4: 350-70.
73. Ständer S, Schürmeyer-Horst F, Luger TA et al. Treatment of pruritic diseases with topical calcineurin inhibitors. Therapeutics and Clinical Risk Management 2006; 2: 213-8.
74. Eberlein B, Eicke C, Reinhardt HW et al. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). Journal of the European Academy of Dermatology and Venereology 2008; 22: 73-82.
75. Bergasa NV, McGee M, Ginsburg IH et al. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology 2006; 44: 1317-23.
76. Brune A, Metze D, Luger TA et al. Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon. Offene, nicht placebokontrollierte Anwendung bei 133 Patienten. Hautarzt 2004; 55: 1130-6.
77. Bergasa NV, Alling DW, Talbot TL et al. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. Journal of the American Academy of Dermatology 1999; 41: 431-4.
78. Kumagai H, Ebata T, Takamori K et al. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrology Dialysis Transplantation 2010; 25: 1251-7.
79. Zylicz Z, Krajnik M, Sorge AA et al. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. Journal of Pain and Symptom Management 2003; 26: 1105-12.
80. Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. Journal of Pain and Symptom Management 1998; 16: 121-4.
81. Davis MP, Frandsen JL, Walsh D et al. Mirtazapine for pruritus. Journal of Pain and Symptom Management 2003; 25: 288-91.
82. Shohrati M, Tajik A, Harandi AA et al. Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed 2007; 6: 70-2.
83. Siepmann D, Luger TA, Ständer S. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series. Journal der Deutschen Dermatologischen Gesellschaft 2008; 6: 941-5.
84. Dunford PJ, Williams KN, Desai PJ et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. Journal of Allergy and Clinical Immunology 2007; 119: 176-83.